bpc-157 tga BPC 157 | Gastric Pentadecapeptide Therapeutic Goods Administration issues safety

In research contexts, it is studied as a discrete pentadecapeptide with reproducible physicochemical properties, allowing its use in biochemical, cellular, and preclinical experimental systems

This material is supplied exclusively as a laboratory reference compound

It does not replace the organisations own assessment of its procedures, exposure routes and controls

Peptides act like messengers, signaling cells in the body to respond in specific ways

the label also warns that rash, hives, or swelling of the face, mouth, lips, or tongue can signal a hypersensitivity reaction requiring emergency care, though no generalized allergic reactions were documented in the original trials Because current supply comes only from compounded preparations rather than an FDA-verified finished product, potency, purity, and sterility can vary by pharmacy, and unregulated online sources carry added contamination or mislabeling risk

It is very stable and applied dissolved in sterile saline, without any additional carriers